Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program.
* This webinar recording contains edits to content requested by the company.
December 3, 2020 /
by: Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program.
* This webinar recording contains edits to content requested by the company.
